Story

UBS Downgrades M&G to 'Sell,' Citing Stretched Valuation After Stock Rally

ENTHMSVIIDZHZH-TWJAKOHI
Aug 11, 20262 min read
UBS Downgrades M&G to 'Sell,' Citing Stretched Valuation After Stock Rally
Text size
Background

Shares in M&G Plc tumbled on Tuesday after analysts at UBS downgraded the UK insurer and asset manager to “Sell” from “Neutral,” citing a stretched valuation following a significant stock price rally this year. The bank’s note suggested the risk-reward profile is now skewed to the downside, prompting a 3.2% drop in M&G’s stock price in morning trading.

Valuation Concerns Drive Downgrade

UBS analysts argued that a more than 25% year-to-date surge in M&G's share price has run ahead of the company's intrinsic value. While the bank raised its 12-month price target to 330 pence, it noted this still represents a 9% downside from Monday's closing level.

The core of the valuation concern stems from M&G's dividend yield. According to the report, the rally has compressed the estimated fiscal year 2028 dividend yield to approximately 6%, which is below its peer group average of 7% and its own historical average of 9.5%. Furthermore, UBS highlighted that the excess yield M&G offers over UK risk-free rates has shrunk to just 1.5%, compared to a historical average of 6.5%.

Headwinds for Flows and Capital

Beyond valuation, UBS flagged potential operational challenges. The note cited a recent slip in M&G’s wholesale fund performance rankings, which fell to third place among European peers in the second quarter of 2026. This marked the first time in five years the firm was not in a top-two position, a development UBS warned could weigh on future net inflows.

Sample IUX Markets – In-articleAd

The bank also pointed to potential constraints on capital returns. While estimating that the firm's insurance unit has distributable reserves of around £1.8 billion—enough to fund about three years of remittances—it cautioned that higher interest rates could erode these financial buffers.

Takeover Prospects Diminish

Analysts at UBS also downplayed the likelihood of a full takeover by partner Dai-ichi Life, a prospect that had helped fuel the stock’s rally since being announced in May 2025. The report stated that the investment case for the Japanese insurer to build its stake has weakened due to a stronger British pound against the yen and rising Japanese government bond yields.

"We do not believe that M&G is a full takeover target from Dai-ichi in the medium-term," the analysts concluded in the note.

Read next

More on Stocks
Back to latest news

LATEST